Description du projet
Formation à la fabrication pharmaceutique verte et numérique
L’industrie pharmaceutique européenne est confrontée à un défi de taille en matière d’écologisation et de numérisation de ses processus de fabrication. La pénurie d’ingénieurs et de scientifiques qualifiés entrave les progrès dans ce domaine. Dans ce contexte, le projet GreenDigiPharma, financé par l’UE, produira une cohorte de dix diplômés de doctorat hautement qualifiés et formés qui constitueront le fer de lance de la transformation verte et numérique de la fabrication pharmaceutique dans les milieux universitaires et industriels. Le projet se concentrera sur les questions urgentes en matière de fabrication durable et s’intéressera à des méthodes plus écologiques pour la production de produits pharmaceutiques, en incorporant des technologies innovantes telles que les nanocatalyseurs hétérogènes et la biocatalyse, de nouvelles techniques de purification et des outils de numérisation. Le programme GreenDigiPharma fournira également aux chercheurs en début de carrière des connaissances scientifiques et transférables sur les droits de propriété intellectuelle, l’esprit d’entreprise, la gestion des données et l’innovation.
Objectif
Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes.
This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments. The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.
Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.
Champ scientifique
- natural scienceschemical sciencesorganic chemistry
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyindustrial biotechnologybioprocessing technologies
- engineering and technologychemical engineeringchemical process engineering
- natural scienceschemical sciencescatalysisbiocatalysis
Mots‑clés
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Régime de financement
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinateur
20133 Milano
Italie